시장보고서
상품코드
1469198

의약품 유리 포장 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 약제 유형별, 지역별, 경쟁사별(2019-2029년)

Pharmaceutical Glass Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Vials, Bottles, Cartridges & Syringes, Ampoules), By Drug Type, By Region and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 187 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 의약품 유리 포장 시장 규모는 2023년 189억 2,000만 달러에 달하고, 2029년까지 연평균 5.25%로 예측 기간 동안 꾸준히 성장할 것으로 예상됩니다. 의약품 유리 포장 세계 시장은 의약품의 안전과 무결성을 보장하기 위해 제약 산업에서 매우 중요한 요소로 자리 잡고 있습니다. 유리 포장은 불활성 특성, 가스 및 습기에 대한 불투과성, 의약품의 효능과 안정성을 유지하는 능력으로 인해 각광을 받고 있습니다. 세계 의약품 유리 포장 시장은 안전하고 효율적인 포장 솔루션에 대한 제약 분야의 수요 증가로 인해 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 이 시장은 병, 바이알, 앰플, 주사기 등 다양한 유리 포장 제품을 포함하며, 각 제품은 제약 공급망에서 특정 목적을 위해 사용됩니다.

세계 인구의 증가와 만성 질환의 확산으로 인해 제약 산업이 성장하고 있습니다. 이러한 의약품 생산의 급증은 고품질 포장 솔루션에 대한 수요에 직접적인 영향을 미치며 유리가 선호되는 재료로 부상하고 있습니다. 전 세계 정부와 규제 기관은 제품의 안전과 품질을 보장하기 위해 의약품 포장에 대한 엄격한 기준을 마련하고 있습니다. 유리 포장은 이러한 규정을 준수하고 오염에 대한 효과적인 장벽을 제공하여 의약품의 효능을 유지합니다.

주요 시장 촉진요인

제약 산업의 성장세 증가

소비자 의식의 증가

주요 시장 과제

비용 압력

주요 시장 동향

기술의 발전

부문별 인사이트

제품별 인사이트

약제 종류별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 의약품 유리 포장 세계 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별(바이알(대·소), 보틀(대·소), 카트리지, 시린지, 앰플)
    • 약제 유형별(제네릭, 브랜드, 생물학적 제제)
    • 지역별
    • 기업별(2023년)
  • 시장 맵
    • 제품별
    • 약제 유형별
    • 지역별

제5장 아시아태평양의 의약품 유리 포장 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 약제 유형별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제6장 유럽의 의약품 유리 포장 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 약제 유형별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 스페인
    • 이탈리아
    • 영국

제7장 북미의 의약품 유리 포장 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 약제 유형별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제8장 남미의 의약품 유리 포장 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 약제 유형별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제9장 중동 및 아프리카의 의약품 유리 포장 시장 전망

  • 시장 규모 예측
    • 금액별
  • 시장 점유율 예측
    • 제품별
    • 약제 유형별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제10장 시장 역학

  • 성장 촉진요인
  • 과제

제11장 시장 동향과 발전

  • 최근의 동향
  • 제품 발표
  • 인수합병

제12장 세계의 의약품 유리 포장 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제14장 경쟁 상황

  • Corning Incorporated
  • Heartsine Technologies, Inc.
  • Nipro Corporation
  • SGD S.A.
  • Stoelzle Oberglas GmbH
  • Bormioli Pharma S.p.A.
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • ShandongPharmaceuticalGlass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Sisecam Group
  • Owens-Illinois, Inc.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm 24.05.03

Global Pharmaceutical Glass Packaging Marketwas valued at USD 18.92 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global pharmaceutical glass packaging market has been a crucial component of the pharmaceutical industry, ensuring the safety and integrity of drugs and medicines. Glass packaging has gained prominence due to its inert nature, impermeability to gases and moisture, and its ability to maintain the potency and stability of pharmaceutical products.The global pharmaceutical glass packaging market has witnessed significant growth in recent years, driven by the rising demand for safe and efficient packaging solutions in the pharmaceutical sector. The market encompasses a wide range of glass packaging products, including bottles, vials, ampoules, and syringes, each serving a specific purpose in the pharmaceutical supply chain.

The increasing global population, coupled with a growing prevalence of chronic diseases, has propelled the pharmaceutical industry. This surge in pharmaceutical manufacturing has directly impacted the demand for high-quality packaging solutions, with glass emerging as a preferred material. Governments and regulatory bodies worldwide have implemented stringent standards for pharmaceutical packaging to ensure product safety and quality. Glass packaging complies with these regulations, providing an effective barrier against contamination and maintaining the efficacy of drugs.

Key Market Drivers

Rising Pharmaceutical Industry Growth is Driving the Global Pharmaceutical Glass Packaging Market.

The pharmaceutical industry has been experiencing robust growth in recent years, driven by increasing global healthcare needs, advancements in medical research, and a growing population. This expansion has, in turn, led to a surge in demand for efficient and secure packaging solutions to ensure the safety and integrity of pharmaceutical products. As a result, the global pharmaceutical glass packaging market has witnessed substantial growth, playing a crucial role in safeguarding and preserving the potency of pharmaceutical formulations.The pharmaceutical industry's remarkable growth can be attributed to several factors. Advances in medical research and technology have led to the development of innovative drugs and therapies, addressing previously untreatable conditions. Additionally, the rising prevalence of chronic diseases, coupled with an aging population, has increased the demand for pharmaceutical products globally.

Moreover, the ongoing global efforts to combat pandemics and the increasing focus on preventive healthcare have further fueled the expansion of the pharmaceutical sector. Governments and private entities are investing significantly in research and development, driving the creation of new drugs and treatment modalities. Pharmaceutical products are highly sensitive to environmental factors such as light, moisture, and air. Maintaining the stability and efficacy of these products is paramount to ensure patient safety and compliance. Glass packaging has emerged as a preferred choice for pharmaceutical products due to its unique properties that address these concerns. Glass offers an impermeable barrier, protecting pharmaceuticals from external contaminants and maintaining their chemical stability. It is also inert, meaning it does not react with the contents, preventing any leaching of harmful substances into the drugs. Furthermore, glass is transparent, allowing for easy visual inspection of the product, and it is fully recyclable, aligning with the growing global focus on sustainable packaging solutions.

Rising Consumer Awareness is Driving the Global Pharmaceutical Glass Packaging Market

In recent years, the global pharmaceutical glass packaging market has experienced significant growth, propelled by the increasing awareness among consumers regarding the importance of safe and secure packaging for pharmaceutical products. The pharmaceutical industry is witnessing a paradigm shift towards glass packaging due to its numerous advantages, including safety, sustainability, and the ability to protect the integrity of sensitive drugs. This surge in consumer awareness is playing a pivotal role in shaping the market dynamics and fueling its expansion. Consumers today are more informed and discerning than ever before, and this trend is particularly evident in the pharmaceutical sector. There is a growing understanding among consumers about the potential risks associated with improper packaging of pharmaceutical products. Glass, being inert and non-reactive, is considered one of the safest materials for packaging medicines. It prevents contamination, ensures product stability, and protects the efficacy of the drugs throughout their shelf life.

The rise in awareness regarding the potential leaching of harmful chemicals from plastic packaging into medicines has led to a preference for glass as a packaging material. The transparency of glass also allows consumers to visually inspect the contents, ensuring both product authenticity and quality. These factors have contributed to a significant shift in consumer preferences towards pharmaceutical glass packaging. Another critical factor contributing to the surge in demand for pharmaceutical glass packaging is the growing emphasis on sustainability. As consumers become more environmentally conscious, there is an increasing aversion to single-use plastics and other non-biodegradable materials. Glass, being recyclable and eco-friendly, aligns with the global push towards sustainable practices. The pharmaceutical industry, in response to consumer demands for sustainable packaging solutions, is adopting glass as a preferred choice. The recyclability of glass not only reduces the carbon footprint but also aligns with the pharmaceutical industry's commitment to environmental responsibility.

The pharmaceutical glass packaging market is witnessing technological advancements and innovations to address the evolving needs of the industry and consumers. Manufacturers are investing in research and development to create glass packaging solutions that offer enhanced protection, longer shelf life, and improved user convenience. One notable development is the incorporation of smart packaging technologies. Smart pharmaceutical glass packaging can provide real-time information about the condition of the drugs, ensuring better adherence to storage and usage guidelines. This innovation is well-received by consumers who appreciate the additional layer of safety and reliability.

Key Market Challenges

Cost Pressures

One of the primary contributors to cost constraints in the pharmaceutical glass packaging market is the fluctuating prices of raw materials. The production of high-quality pharmaceutical glass requires specific materials such as silica sand, soda ash, and limestone. Any volatility in the prices of these essential components directly influences the overall production cost. Additionally, geopolitical factors, supply chain disruptions, and environmental regulations can contribute to raw material cost fluctuations, making it challenging for manufacturers to maintain stable pricing. The energy-intensive nature of glass manufacturing adds another layer of challenge to the industry. Melting and forming glass into intricate shapes demands substantial amounts of energy. As the global push for sustainable practices intensifies, pharmaceutical glass packaging manufacturers are under pressure to adopt eco-friendly production processes. However, implementing such changes often involves upfront capital investments, posing financial challenges for companies already grappling with cost constraints.

Keeping up with technological advancements is crucial for pharmaceutical glass packaging manufacturers to stay competitive and meet evolving industry standards. However, integrating new technologies into production processes requires significant investments. Companies facing cost constraints may find it difficult to allocate funds for research and development, hindering their ability to adopt innovations that enhance product quality and manufacturing efficiency. The pharmaceutical industry is heavily regulated, and adherence to stringent quality standards is non-negotiable. Meeting regulatory requirements often involves investing in sophisticated testing equipment, quality control measures, and compliance management systems. The associated costs, while necessary for ensuring product safety, can strain the financial resources of glass packaging manufacturers, especially those operating on tight budgets.

Key Market Trends

Technological Advancements

The field of life sciences and clinical research has been witnessing a paradigm shift, driven by rapid technological advancements. One of the key contributors to this transformation is the evolution of microplate systems. These systems play a pivotal role in various applications, ranging from drug discovery and genomics to diagnostics and bioassays. The global microplate systems market is experiencing significant growth, propelled by innovative technologies that enhance efficiency, accuracy, and throughput in laboratory processes. Microplate systems have evolved from manual processes to highly automated and high-throughput systems. Automation not only accelerates the research and testing processes but also minimizes the chances of human error. The integration of robotic systems and advanced liquid handling technologies has greatly increased the speed and accuracy of experiments.

The integration of cutting-edge detection technologies, such as fluorescence, luminescence, and absorbance, has revolutionized microplate assays. These technologies provide researchers with enhanced sensitivity and specificity, allowing for the detection of even low-abundance biological molecules. This is particularly crucial in drug discovery and genomics research. Miniaturization of assays has become a key trend in microplate systems. By using smaller volumes of reagents and samples, researchers can reduce costs and improve efficiency. Multiplexing, which involves running multiple assays simultaneously, further amplifies the capabilities of microplate systems, allowing for the study of multiple parameters in a single experiment. The integration of informatics solutions with microplate systems has streamlined data management and analysis. Advanced software platforms enable researchers to collect, analyze, and interpret data more efficiently, contributing to faster decision-making processes. This integration is particularly valuable in industries like pharmaceuticals, where large-scale data processing is a common requirement.

Segmental Insights

Product Insights

Basedon the category of Product, bottles emerged as the dominant segment in the global market for Pharmaceutical Glass Packaging in 2023.Glass bottles have long been favored in the pharmaceutical industry due to their superior barrier properties. Glass is impermeable, ensuring that pharmaceutical products are protected from external elements, such as moisture, gases, and contaminants. This is crucial for maintaining the stability and efficacy of drugs, particularly those sensitive to environmental factors.Unlike some plastic alternatives, glass is chemically inert and does not react with the contents of the bottle. This property is essential for pharmaceutical products, as any interaction between the packaging material and the drug could compromise its quality. Glass bottles provide a secure and stable environment for a wide range of medications.

The pharmaceutical industry operates under strict regulatory frameworks globally. Glass is a well-established material that meets these stringent standards. It is inert, non-toxic, and does not leach harmful substances into the pharmaceutical formulations. As regulatory scrutiny intensifies, pharmaceutical companies are opting for glass bottles to ensure compliance and gain the trust of regulatory authorities. Glass bottles offer versatile design options, allowing for various shapes and sizes to accommodate different pharmaceutical products. This flexibility in design is particularly important for medications that require specific packaging configurations, such as injectables, oral liquids, and parenteral drugs. The adaptability of glass makes it a preferred choice for pharmaceutical companies seeking customizable solutions. With an increasing focus on sustainable practices, pharmaceutical companies are turning to eco-friendly packaging solutions. Glass bottles are fully recyclable and have a minimal environmental impact compared to certain plastic alternatives. The pharmaceutical industry's commitment to reducing its carbon footprint has further propelled the adoption of glass packaging. Recent advancements in glass manufacturing technologies have enhanced the quality and efficiency of glass bottles for pharmaceutical use. Precision in molding, improved surface treatments, and innovations in glass composition contribute to the production of high-quality, reliable, and visually appealing packaging solutions. Glass offers unparalleled stability over time, ensuring the extended shelf life of pharmaceutical products. The material's resistance to degradation and permeation makes it ideal for drugs that require extended storage durations.

Drug Type Insights

The Generic segment is projected to experience rapid growth during the forecast period. Generic drugs, also known as off-patent drugs, are bioequivalent versions of brand-name pharmaceuticals. They contain the same active ingredients, have the same strength and dosage form, and are administered in the same way. The key difference lies in the absence of patent protection for generic drugs, allowing multiple manufacturers to produce and market them. This competition typically leads to lower prices, making healthcare more affordable and accessible to a broader population. The rise of generic drugs has reshaped the pharmaceutical landscape, impacting not only drug manufacturing but also the packaging industry. Pharmaceutical glass packaging, known for its superior qualities in preserving drug integrity, has become the material of choice for packaging generic medications. The glass offers a barrier against moisture, gases, and external contaminants, ensuring the stability and efficacy of the drugs over an extended period.

Regional Insights

North America emerged as the dominant player in the global Pharmaceutical Glass Packaging market in 2023, holding the largest market share in terms of value. North American companies have been at the forefront of technological advancements in the pharmaceutical packaging industry. Cutting-edge technologies, such as advanced glass formulations and coating techniques, have enabled manufacturers to produce glass packaging that meets the stringent requirements of the pharmaceutical sector. These innovations ensure the integrity, safety, and stability of pharmaceutical products during storage and transportation. The pharmaceutical industry is subject to rigorous regulatory standards to ensure the safety and efficacy of drugs. North America, particularly the United States and Canada, has established stringent regulatory frameworks governing pharmaceutical packaging. The compliance with these standards has become a key differentiator for North American glass packaging manufacturers, giving them a competitive edge in the global market.

Key Market Players

Corning Incorporated

Heartsine Technologies, Inc.

Nipro Corporation

SGD S.A.

Stoelzle Oberglas GmbH

Bormioli Pharma S.p.A.

West Pharmaceutical Services, Inc.

Schott AG

Gerresheimer AG

ShandongPharmaceuticalGlass Co., Ltd.

Beatson Clark

Ardagh Group S.A

Arab Pharmaceutical Glass Co.

Piramal Enterprises Ltd.

Sisecam Group

Owens-Illinois, Inc.

Report Scope:

In this report, the Global Pharmaceutical Glass Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Glass Packaging Market,By Product:

  • Vials
  • Bottles
  • Cartridges Syringes
  • Ampoules

Pharmaceutical Glass Packaging Market,By Drug Type:

  • Generic
  • Branded
  • Biologic

Pharmaceutical Glass Packaging Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Pharmaceutical Glass Packaging Market.

Available Customizations:

Global Pharmaceutical Glass Packaging marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Pharmaceutical Glass Packaging Market Outlook

  • 4.1.Market Size Forecast
    • 4.1.1.By Value
  • 4.2.Market Share Forecast
    • 4.2.1.ByProduct (Vials (Small vials, Large vials), Bottles(Small bottles, Large bottles), Cartridges Syringes, Ampoules)
    • 4.2.2.By Drug Type (Generic, Branded, Biologic)
    • 4.2.3.By Region
    • 4.2.4.By Company (2023)
  • 4.3.Market Map
    • 4.3.1.By Product
    • 4.3.2.By Drug Type
    • 4.3.3.By Region

5.Asia Pacific Pharmaceutical Glass Packaging Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Product
    • 5.2.2.By Drug Type
    • 5.2.3.By Country
  • 5.3.Asia Pacific: Country Analysis
    • 5.3.1.China Pharmaceutical Glass Packaging Market Outlook
      • 5.3.1.1.Market Size Forecast
        • 5.3.1.1.1.By Value
      • 5.3.1.2.Market Share Forecast
        • 5.3.1.2.1.By Product
        • 5.3.1.2.2.By Drug Type
    • 5.3.2.India Pharmaceutical Glass Packaging Market Outlook
      • 5.3.2.1.Market Size Forecast
        • 5.3.2.1.1.By Value
      • 5.3.2.2.Market Share Forecast
        • 5.3.2.2.1.By Product
        • 5.3.2.2.2.By Drug Type
    • 5.3.3.Australia Pharmaceutical Glass Packaging Market Outlook
      • 5.3.3.1.Market Size Forecast
        • 5.3.3.1.1.By Value
      • 5.3.3.2.Market Share Forecast
        • 5.3.3.2.1.By Product
        • 5.3.3.2.2.By Drug Type
    • 5.3.4.Japan Pharmaceutical Glass Packaging Market Outlook
      • 5.3.4.1.Market Size Forecast
        • 5.3.4.1.1.By Value
      • 5.3.4.2.Market Share Forecast
        • 5.3.4.2.1.By Product
        • 5.3.4.2.2.By Drug Type
    • 5.3.5.South Korea Pharmaceutical Glass Packaging Market Outlook
      • 5.3.5.1.Market Size Forecast
        • 5.3.5.1.1.By Value
      • 5.3.5.2.Market Share Forecast
        • 5.3.5.2.1.By Product
        • 5.3.5.2.2.By Drug Type

6.Europe Pharmaceutical Glass Packaging Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Product
    • 6.2.2.By Drug Type
    • 6.2.3.By Country
  • 6.3.Europe: Country Analysis
    • 6.3.1.France Pharmaceutical Glass Packaging Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Product
        • 6.3.1.2.2.By Drug Type
    • 6.3.2.Germany Pharmaceutical Glass Packaging Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Product
        • 6.3.2.2.2.By Drug Type
    • 6.3.3.Spain Pharmaceutical Glass Packaging Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Product
        • 6.3.3.2.2.By Drug Type
    • 6.3.4.Italy Pharmaceutical Glass Packaging Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Product
        • 6.3.4.2.2.By Drug Type
    • 6.3.5.United Kingdom Pharmaceutical Glass Packaging Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Product
        • 6.3.5.2.2.By Drug Type

7.North America Pharmaceutical Glass Packaging Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Product
    • 7.2.2.By Drug Type
    • 7.2.3.By Country
  • 7.3.North America: Country Analysis
    • 7.3.1.United States Pharmaceutical Glass Packaging Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Product
        • 7.3.1.2.2.By Drug Type
    • 7.3.2.Mexico Pharmaceutical Glass Packaging Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Product
        • 7.3.2.2.2.By Drug Type
    • 7.3.3.Canada Pharmaceutical Glass Packaging Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Product
        • 7.3.3.2.2.By Drug Type

8.South America Pharmaceutical Glass Packaging Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Product
    • 8.2.2.By Drug Type
    • 8.2.3.By Country
  • 8.3.South America: Country Analysis
    • 8.3.1.Brazil Pharmaceutical Glass Packaging Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Product
        • 8.3.1.2.2.By Drug Type
    • 8.3.2.Argentina Pharmaceutical Glass Packaging Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Product
        • 8.3.2.2.2.By Drug Type
    • 8.3.3.Colombia Pharmaceutical Glass Packaging Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Product
        • 8.3.3.2.2.By Drug Type

9.Middle East and Africa Pharmaceutical Glass Packaging Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Product
    • 9.2.2.By Drug Type
    • 9.2.3.By Country
  • 9.3.MEA: Country Analysis
    • 9.3.1.South Africa Pharmaceutical Glass Packaging Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Product
        • 9.3.1.2.2.By Drug Type
    • 9.3.2.Saudi Arabia Pharmaceutical Glass Packaging Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Product
        • 9.3.2.2.2.By Drug Type
    • 9.3.3.UAE Pharmaceutical Glass Packaging Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Product
        • 9.3.3.2.2.By Drug Type

10.Market Dynamics

  • 10.1.Drivers
  • 10.2.Challenges

11.Market Trends Developments

  • 11.1.Recent Developments
  • 11.2.Product Launches
  • 11.3.Mergers Acquisitions

12.Global Pharmaceutical Glass Packaging Market: SWOT Analysis

13.Porter's Five Forces Analysis

  • 13.1.Competition in the Industry
  • 13.2.Potential of New Entrants
  • 13.3.Power of Suppliers
  • 13.4.Power of Customers
  • 13.5.Threat of Substitute Product

14.Competitive Landscape

  • 14.1.Corning Incorporated
    • 14.1.1.Company Snapshot
    • 14.1.2.Product Services
    • 14.1.4.Financials (In case of listed)
    • 14.1.5.Recent Developments
    • 14.1.6.SWOT Analysis
  • 14.2.Heartsine Technologies, Inc.
  • 14.3.Nipro Corporation
  • 14.4.SGD S.A.
  • 14.5.Stoelzle Oberglas GmbH
  • 14.6.Bormioli Pharma S.p.A.
  • 14.7.West Pharmaceutical Services, Inc.
  • 14.8.Schott AG
  • 14.9.Gerresheimer AG
  • 14.10.ShandongPharmaceuticalGlass Co., Ltd.
  • 14.11.Beatson Clark
  • 14.12.Ardagh Group S.A
  • 14.13.Arab Pharmaceutical Glass Co.
  • 14.14.Piramal Enterprises Ltd.
  • 14.15.Sisecam Group
  • 14.16.Owens-Illinois, Inc.

15.Strategic Recommendations

16. About Us Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제